Warenkorb 0

Congratulations! Your order qualifies for free shipping Sie sind 45 zł von kostenlosem Versand entfernt.
Sorry, looks like we don't have enough of this product.

Privatkunde
Geschäftskunde
Bitte geben Sie eine gültige USt-IdNr. ein.
Subtotal Free
Shipping, taxes, and discount codes are calculated at checkout

Vitamin C - Biochemistry and Therapeutic Application

Vitamin C - Biochemie und therapeutische Anwendung

Vitamin C – just like the B vitamins – is one of the water-soluble vitamins (and water-soluble antioxidants).

In the organism, it occurs in its active, reduced form as ascorbic acid and in its inactive, oxidized form as dehydroascorbic acid.


Bioavailability decreases with oral dose:

Orally ingested vitamin C is actively absorbed via sodium-dependent transporters (using energy). In the blood, it is v.a. It is transported as dehydroascorbic acid and then reduced back to ascorbic acid in the tissue/cells using glutathione.

The absorption rate, d.h. The proportion of orally administered vitamin C that actually reaches the cells decreases with increasing dose. With a single dose of 100 mg, approximately 90% of the ingested amount reaches the cells, while with 3000 mg this value drops to only 40%.

Absorption rate

Single dose (mg)

Amount absorbed (mg)

90%

100

90

60-75%

1000

600-750

40%

3000

1200

16%

120,000

1920


However, absorption can be improved by

  • Esterification of calcium ascorbate (“Ester C”) and
  • in combination with bioflavonoids

The lower dose of vitamin C complex in natural plants appears to be particularly bioavailable. (Source: Kober S Bush MJ et al.; Res Comm Chem Pathol and Pharmacol 1987; 137-140; Wright JV et al.; Int Clin Nutrition Rev 1990; 10; 267-270).

Low-dose oral vitamin C supplements Up to 500 mg doses have a high bioavailability of up to 95% when actively transported. %. Therefore, it is recommended to divide the vitamin C intake into several doses.. At higher doses, bioavailability decreases rapidly. A liposomal preparation should be more effective here (in Davis's study, 4 g of "normal" and 4 g of liposomal vitamin C were compared).

Vitamin C plasma levels:


Source: Pascoe

Vitamin C dose-response relationship:


Source: Modified from Hahn A et al.; Dtch Apoth Ztg 2004; 144; 43-60

Dosage recommendations:

Effects of Vitamin C:

  • Electron donor and reducing agent (details: s.u. )
  • Antioxidant effect
  • Numerous enzymes are vitamin C-dependent.
  • Immune effect (improvement of immune competence)
    • Histamine, bacteria, thromboxane ↓
    • Phagocytosis, interferon, PGE2, PGI2, IgM, IgA, IgG, and leukocyte mobility and chemotaxy ↑
  • Anti-allergic effect as an antihistamine (supports histamine breakdown)
  • Involved in Phase I detoxification (pollutant functionalization), z.B. Hydroxylation of steroids, heavy metals, nitrosamines and bile acids (stimulation of the cytochrome P450 family)
  • Reduction of Folic acid to dihydrofolic acid (and to tetrahydrofolic acid)
    -> Folic acid reductase (vitamin C-dependent)
  • Cofactor in the reduction of folic acid to dihydrofolic acid and in the activation of vitamin D
  • Cofactor in the biosynthesis of
    • Collagen (and other connective tissue building blocks) through hydroxylation of proline and lysine residues to hydroxy amino acid residues.
      • Prolyl-4-hydroxylase
      • Lysyl-5-hydroxylase
    • Carnitine (from lysine)
      • Trimethyllysine α-ketoglutarate dioxygenase
      • γ-Butyrobetaine-α-ketoglutarate dioxygenase
    • Serotonin and catecholamines (z.B. (Dopamine)
      • Dopamine β-monooxygenase (hydroxylates dopamine -> Norepinephrine)
      • Tryptophan hydroxylase (hydroxylated tryptophan -> 5 HTP)
    • Glucocorticoids and corticosterones --> 11,18,21-Hydroxylase
  • Tyrosine degradation to fumarate and acetoacetate --> 4-Hydroxyhenylpyruvate dioxygenase
  • Activation of peptide hormones
    • such asCorticotropin-releasing hormone (CRH), TRH, gastrin, ADH, GRH, bombesin, calcitonin, pancreozymin, cholecystokinin, VIP, ACTH, u.a.
    • by α-amidation at the C-end
    • Peptidylglycine α-amidation monooxygenase
  • Complex formation (chelation as a ligand for metal ions) à Vitamin C is a ligand for metal ions:
    • Improvement of Fe absorption (u.a. metal ions) by a factor of 4
    • Vitamin C complexes Fe (formation of Fe2+ chelates)
    • Vitamin C reduces Fe3+ to Fe2+
  • Improvement of oxygen uptake (z.B. (in sports)
  • Cholesterol reduction
    • to 7α-hydroxycholesterol (--> 7α-Hydroxylase), bile acids, vitamin D

Vitamin C as an electron donor and reducing agent:

  • Antioxidant effect (through oxidation of L-ascorbic acid to biologically inactive dehydroascorbic acid)
    • Breakdown of superoxide radical to H2O2 and hydroxyl radical to H2O
    • Reduction of oxidized antioxidants (such as GSH, Vit E)
    • Protection of healthy cells

But:

  • Pro-oxidative effect on damaged cells and bacteria: Reduces transition metals such as Fe3+ (to Fe2+) and Cu2+ (to Cu+) and generates hydroxyl radicals.

    Vitamin C with antioxidant and pro-oxidative effects:

    Indications for vitamin C supplementation:

    • Scurvy (Vitamin C as the only possible therapy)
    • Oncology (Details: s.u. )
    • Susceptibility to infection
    • Infections (z.B. Herpes, Candida albicans, Helicobacter pylori)
    • Allergies (histamine), autoimmune diseases, asthma
    • Orthopedic disorders (e.g., lumbosacral radiculopathy, Sudeck's atrophy, bone formation disorders)
    • Metabolic diseases (z.B. Diabetes mellitus, gout)
    • Cardiovascular diseases
    • Mental disorders (z.B. Stress, depression)
    • Neurological and eye diseases
    • Surgery, burns and wound healing
    • Diseases of the gastrointestinal tract (z.B. Gallstones, pancreatitis)
    • Gastrointestinal side effects of ASA and NSAIDs
    • Seasickness (to lower histamine)

    Vitamin C in oncology:

    • Protection of healthy cells (antioxidant effect)
      • in prevention (DNA damage caused by radicals) , Repair mechanisms and apoptosis )
      • in therapy (side effects of radicals during radiation, chemotherapy) )
    • Independent cytotoxic effect without systemic toxicity
      • Effect of basic therapy
      • Resistance to basic therapy
    • Modulation of inflammation and the immune system
    • detoxification function
    • Consequences of tumor and therapy (z.B. Fatigue, cachexia, pain)
    • regeneration (incl.Wound healing)
    • metabolism (z.B. Vitamin C as a cofactor)

    --> Shortening of the recovery period
    --> Improving quality of life
    --> Extended survival time


    (Source: Dr. Udo Böhm, 2015)

    Examples of increased vitamin C requirements:

    • pregnancy
    • dialysis
    • Smoke
    • Infections
    • Injuries and operations
    • cancer or diabetes
    • Medication intake

    Possible symptoms of vitamin C deficiency:

    • Higher risk of infection and cancer
    • Exhaustion, fatigue
    • depression
    • Hair loss, poor hair structure
    • Poor wound healing
    • Gingivitis and tooth loss
    • Perifollicular petechiae (in the area of ​​the extremities)
    • Papules and ecchymoses
    • Hemarthrosis
    • Subperiosteal hemorrhages
    • Joint inflammation
    • Myalgia
    • Muscle atrophy
    • Cardiomyopathy
    • Microcytic anemia (with iron absorption disorder)

    Possible side effects of vitamin C:

    In general, vitamin C has very low toxicity and a wide dosage range without relevant side effects. At very high (pharmacological) dosage The following side effects may occur:

    • Diarrhea
    • Thirst, feeling cold, dizziness, urge to urinate
    • Stomach cramps and vomiting (especially when taken on an empty stomach) à use salt (z.B. sodium ascorbate) and should not be taken on an empty stomach.
    • Pro-oxidative effect (z.B. (desired in oncology)
    • It reduces transition metals such as Fe3+ and Cu2+ and may generate hydroxyl radicals (at high levels of Fe and Cu).
    • Complex formation with inorganic selenite
    • Risk of hemolysis in genetically determined glucose-6-phosphate dehydrogenase (G6PH) deficiency
    • Increased oxalic acid excretion (risk of calcium oxalate stones in patients with a history of kidney stones)
    • Reduction in the effect of anticoagulants (at higher doses)